ANEE KAUR: Open Payments
NPI 1417560970 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 58 payments from 8 companies in 2025. Trend: 2023 $764 · 2024 $1,229 · 2025 $1,001
Food & beverage: $992Education: $9
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 16 | $345 |
| Otsuka America Pharmaceutical, Inc. | 9 | $172 |
| ABBVIE INC. | 18 | $167 |
| Lundbeck LLC | 7 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $80 |
| Neurocrine BioSciences, Inc. | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: REXULTI, VRAYLAR, LYBALVI, ARISTADA, CAPLYTA, INGREZZA, VIVITROL, HETLIOZ.
Industry payments across NC — which companies pay providers there.
